Product Information
SULFAMETHOXAZOLE-TMP SUSP is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.0555 per ML under NDC 70954025810. Its NADAC has been published 221 times since Jul 13, 2022.
FDA first approved this application on Feb 8, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200; 40 mg/5mL; mg/5mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954025810
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SULFAMETHOXAZOLE; TRIMETHOPRIMApproval Type
Generic (ANDA)
FDA Application
ANDA214330FDA Approved
2/8/2022
TE Code
AB
On Market Since
2/8/2022
Pharmacological Classes
Price Statistics
The NADAC for SULFAMETHOXAZOLE-TMP SUSP has been published 221 times since Jul 13, 2022, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0555 per ML |
|---|---|
| All-time high | $0.0702 (Dec 13, 2023) |
| All-time low | $0.0449 (Nov 20, 2024) |
| 52-week high | $0.0610 |
| 52-week low | $0.0551 |
| Median price | $0.0604 |
| Average price | $0.0598 |
| Largest weekly change | +35.7% (Aug 21, 2024) |
| Weeks tracked | 221 |
| Tracking since | Jul 13, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sulfamethoxazole and Trimethoprim market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydrofolate Reductase Inhibitor Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SULFAMETHOXAZOLE-TMP SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SULFAMETHOXAZOLE-TMP SUSP, manufactured by ANI Pharmaceuticals, Inc., is $0.0555 per ML (NDC 70954025810), effective Sep 30, 2026.
How has the price of SULFAMETHOXAZOLE-TMP SUSP changed over time?
Over the history we have for it, the NADAC for SULFAMETHOXAZOLE-TMP SUSP has declined 11.0%. It has been tracked across 221 weekly CMS publications since Jul 13, 2022.
What are the highest and lowest recorded NADAC prices for SULFAMETHOXAZOLE-TMP SUSP?
Since Jul 13, 2022, the NADAC for SULFAMETHOXAZOLE-TMP SUSP has ranged from a low of $0.0449 (Nov 20, 2024) to a high of $0.0702 (Dec 13, 2023), with a median of $0.0604 per ML.
Are there cheaper alternatives to SULFAMETHOXAZOLE-TMP SUSP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SULFAMETHOXAZOLE-TMP SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures SULFAMETHOXAZOLE-TMP SUSP?
SULFAMETHOXAZOLE-TMP SUSP (NDC 70954025810) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.